(Q43818669)

27 November 2017

title

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. (English)

1 reference

27 November 2017

1 reference

1 reference

1 reference

Kweon YO

1

1 reference

27 November 2017

Goodman ZD

2

1 reference

27 November 2017

Dienstag JL

3

1 reference

27 November 2017

Schiff ER

4

1 reference

27 November 2017

Brown NA

5

1 reference

27 November 2017

Burchardt E

6

1 reference

27 November 2017

Schoonhoven R

7

1 reference

27 November 2017

Brenner DA

8

1 reference

27 November 2017

Fried MW

9

1 reference

27 November 2017

publication date

1 December 2001

1 reference

27 November 2017

published in

Journal of Hepatology

1 reference

27 November 2017

volume

35

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

749-755

1 reference

New aspects of hepatic fibrosis

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Lamivudine as initial treatment for chronic hepatitis B in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Fibrosis in patients with chronic hepatitis C: detection and significance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Collagen polymorphism in normal and cirrhotic human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Phenotypic modulation in lipocytes in experimental liver fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Perisinusoidal lipocytes and fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Bone morphogenetic protein-1: the type I procollagen C-proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Epitope-specific monoclonal antibodies against human C-terminal procollagen alpha1(III)-propeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Reversibility of hepatic fibrosis in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900218-5

7 January 2021

10.1016/S0168-8278(01)00218-5

Identifiers

DOI

1 reference

27 November 2017

1 reference